Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: Relevance to Parkinson's disease

Biochemical Pharmacology

Volumn 56, Issue 5, 1998, Pages 645-655

  Merad Boudia, Mansouria ^a   Nicole, Annie ^a   Santiard Baron, Dominique ^a   Saillé, Christophe ^a   Ceballos Picot, Irène ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Apoptosis; Glutathione; Mitochondria; Neuronal cell; Oxidative stress; Parkinson rsquo; s disease

Indexed keywords

DNA FRAGMENT; GLUTATHIONE; LEVODOPA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; MITOCHONDRIAL RESPIRATION; MORPHOLOGY; MOUSE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BUTHIONINE SULFOXIMINE; CELL LINE; ELECTRON TRANSPORT; ENZYME INHIBITORS; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; MICE; MITOCHONDRIA; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARKINSON DISEASE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032169935     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00647-3     Document Type: Article

References (69)

1. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouat-Progent A., Ruberg M., Hirsch E.C., Agid A. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol. 12:1997;25-31.
2. Ceballos I., Agid F., Delacourte A., Defossez A., Nicole A., Sinet P.M. Parkinson's disease and Alzheimer's disease neurodegenerative disorders due to brain antioxidant system deficiency? Emerit I., Packer L., Auclair C. Advances in Experimental Biology and Medicine. 1990;493-498 Plenum Press, New York.
3. Ceballos I., Agid F., Lafon M., Hirsch E., Sinet P.M., Agid Y. Superoxide dismutase and Parkinson's disease. Lancet. 335:1990;1035-1036.
4. Ceballos-Picot I. Oxidative stress in Parkinson's disease. Landes, Springer. The Role of Oxidative Stress in Neuronal Death. 1997;176-197 Landes Company, Georgetown.
5. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol. 32:1992;804-812.
6. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.-P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson's disease. Proc Natl Acad Sci USA. 94:1997;7531-7536.
7. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem. 52:1989;381-389.
8. Kish S.J., Marito C., Hornykiewics O. Glutathione peroxidase activity in Parkinson's disease brain. Neurosci Lett. 58:1985;343-346.
9. Riederer P., Sofic E., Rauch W.D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J Neurochem. 52:1989;512-520.
10. Di Monte D.A., Chan Piu Sandy M.S. Glutathione in Parkinson's disease, A link between oxidative stress and mitochondrial damage? Ann Neurol. 32:1992;S111-S113.
11. Jenner P. Oxidative damage in neurodegenerative diseases. Lancet. 344:1994;796-798.
12. Cleeter M.J.W., Cooper J.M., Schapira A.H.V. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem. 58:1992;786-789.
13. Marsden C.D., Naylor R.J. 1-methyl-4-phenylpyridinium is neurotoxic to the nigrostriatal dopamine pathway. Nature. 319:1986;56-57.
14. Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H.V., Marsden C.D. Brain skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain. 115:1992;333-342.
15. Schapira A.H.V. Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal. Movement Disord. 9:1994;125-138.
16. Glinka Y.Y., Youdim M.B.H. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. European J Pharmacol. 292:1995;329-332.
17. Glinka Y., Tipton K.F., Youdim M.B.H. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J Neurochem. 66:1996;2004-2010.
18. Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 263:1988;17205-17208.
19. Fernandes R.S., Cotter T.G. Apoptosis and necrosis intracellular levels of glutathione influence mode of cell death . Biochem Pharmacol. 48:1994;675-681.
20. Ben-Yoseph O., Boxer P.A., Ross B.D. Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J Neurochem. 66:1996;2329-2337.
21. Sagara J.I., Miura K., Bannai S. Maintenance of neuronal glutathione by glial cells. J Neurochem. 64:1993;1672-1676.
22. Drukarch B., Jongenelen C.A.M., Schepens E., Langeveld C.H., Stoof J.C. Glutathione is involved in the granular storage of dopamine in rat PC12 pheochromocytoma cells: implication for the pathogenesis of Parkinson's disease. J Neurosci. 16:1996;6038-6045.
23. Grasbon-Frodl E.M., Andersson A., Brundin P. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J Neurochem. 67:1996;1653-1660.
24. Andersen J.K., Mo J.Q., Hom D.G., Lee F.Y., Harnish P., Hamill R.W., McNeill T.H. Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J Neurochem. 67:1996;2164-2171.
25. Amano T., Richelson E., Nirenberg M. Neurotransmitter synthesis by neuroblatoma clones. Proc Natl Acad Sci USA. 69:1972;253-258.
26. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
27. Griffith O. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 106:1980;207-212.
28. Ceballos-Picot I., Merad-Boudia M., Nicole A., Thevenin M., Hellier G., Legrain S., Berr C. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type. Place of extracellular glutathione peroxidase. Free Radical Biol Med. 20:1996;579-587.
29. Boitier E., Merad-Boudia M., Guguen-Guillouzo C., Defer N., Ceballos-Picot I., Leroux J.P., Marsac C. Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine-induced rat hepatomas: possible involvement of oxygen free radicals. Cancer Res. 55:1995;3028-3035.
30. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 38:1995;357-366.
31. Sinet P.M., Ceballos-Picot I. Role of free radicals in Alzheimer's disease and Down syndrome. Packer L., Philippo A., Christen Y. Free Radicals in the Brain. 1992;1-98 Springer-Verlag, Heidelberg.
32. Merad-Boudia M., Fideler L., Nicole A., Aral B., Briand P., Sinet P.M., Ceballos-Picot I. Selective modulation of brain antioxidant capacity by genetic or metabolic manipulation. Pasquier C., Olivier R.Y., Auclair C., Packer L. Oxidative Stress in Cell Activation and Viral Infection. 1994;173-192 Birkhauser Verlag, Basel.
33. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-spartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 92:1995;7162-7166.
34. Whittemore E.R., Loo D.T., Cotman C.W. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport. 5:1994;1485-1488.
35. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
36. Ratan R.R., Murphy T.H., Baraban J.M. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem. 62:1994;376-379.
37. Greenlund L.J.S., Deckwerth T.L., Johnson E. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
38. Macho A., Hirsch T., Marzo I., Marchetti P., Dallaporta B., Susin S.A., Zamzani N., Kroemer G. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol. 158:1997;4612-4619.
39. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
40. Bredesen D.E. Neural apoptosis. Ann Neurol. 38:1995;839-851.
41. Slater A.F.G., Stefan C., Nobel I., van den Dobbelsteen D.J., Orrenius S. Intracellular redox changes during apoptosis. Death and Differentiation. 3:1996;57-62.
42. Hockenbury D.M., Olstvai Z.N., Yin X., Milliman C.L., Korsmeyer J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
43. Ellerby L.M., Ellerby H.M., Park S.M., Holleran A.L., Murphy A.N., Fiskum G., Kane D.J., Testa M.P., Kayalar C., Bredesen D.E. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J Neurochem. 67:1996;1259-1267.
44. Han S.-K., Mytilineou C., Cohen G. L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J Neurochem. 66:1996;501-510.
45. Bhave S.V., Johannessen J.N., Lash L.H., Wakade T.D., Wakade A.R. Age-dependent sensitivity of cultured peripheral sympathetic neurons to 1-methyl-4-phenylpyridinium: role of glutathione. J Neurochem. 67:1996;557-565.
46. Heales S.J.R., Bolanos J.P., Clark J.B. Glutathione depletion is accompanied by increased neuronal nitric oxide synthase activity. Neurochem Res. 21:1996;35-39.
47. Gunasekar P.G., Khantasamy A.G., Borowitz J.L., Isom G.E. NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J Neurochem. 65:1995;2016-2021.
48. Schapira A.H.V., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem. 54:1990;823-827.
49. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 36:1994;348-355.
50. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett. 142:1992;128-130.
51. Yong V.W., Perry T.L., Krisman A.A. Depletion of glutathione in brainstem of mice by MPTP is prevented by antioxidant treatment. Neurosci Lett. 63:1986;56-60.
52. Mithofer K., Sandy M.S., Smith S.M., Di Monte D. Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes. Arch Biochem Biophys. 295:1992;132-136.
53. Singer T.P., Ramsay R.R., Sonsalla P.K. Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. Narabayashi H., Nagatsu N., Yanagisawa N., Mizuno Y. Advances in Neurology. 1993;300-312 Raven Press, New York.
54. Meister A. Mitochondrial changes associated with glutathione deficiency. Biochim Biophys Acta. 1271:1995;35-42.
55. Jain A.J., Martensson J., Stole E., Auld P.A.M., Meister A. Glutathione deficiency leads to mitochondrial damage to the brain. Proc Natl Acad Sci USA. 88:1991;1913-1917.
56. Heales S.J.R., Davies S.E.C., Bates T.E., Clark J.B. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res. 20:1995;31-38.
57. Bolanos J.P., Heales S.J.R., Peuchen S., Barker J.E., Land J.M., Clark J.B. Nitric oxide-mediated mitochondrial damage: a potentiel neuroprotective role for glutathione. Free Radical Biol Med. 21:1996;995-1001.
58. Benzi G., Curti D., Pastoris O., Marzatico F., Villa R.F., Dagani F. Sequential damage in mitochondrial complexes by peroxidative stress. Neurochem Res. 16:1991;1295-1302.
59. Benzi G., Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activites linked to mitochondria and the glutathione system. Free Radical Biol Med. 19:1995;77-101.
60. Hartley A., Cooper J.M., Schapira A.H.V. Iron-induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease. Brain Res. 627:1993;349-353.
61. Huang J., Philbert M.A. Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Res. 711:1996;184-192.
62. Hartley A., Stone J.M., Heron C., Cooper J.M., Schapira A.H. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem. 63:1994;1987-1990.
63. Wolvetang E.J., Johnson K.L., Krauer K., Relph S.J., Linnane A.W. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 339:1994;40-44.
64. Richter C., Schweizer M., Cossarizza A., Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett. 378:1996;107-110.
65. Zeewalk G.D., Bernard L.P., Albers D.S., Mirochnitchenko O., Niklas W.J., Sonsalla P.K. Energy stress-induced dopamine loss in glutathione peroxidase-overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures. J Neurochem. 68:1997;426-429.
66. Ankarkrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
67. Liu X., Naekyung C.K., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
68. Hou J.-G., Cohen G., Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J Neurochem. 69:1997;76-83.
69. Griffith O.W., Meister A. Origin and turnover of mitochondrial glutathione. Proc Natl Acad Sci USA. 82:1985;4668-4672.